123 related articles for article (PubMed ID: 38518731)
1. ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/AKT signaling pathway in nasopharyngeal carcinoma.
Xu K; Jiang P; Chen Z; Gu X; Zhang T
Pathol Res Pract; 2024 Apr; 256():155264. PubMed ID: 38518731
[TBL] [Abstract][Full Text] [Related]
2. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
[TBL] [Abstract][Full Text] [Related]
3. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/AKT/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis.
Xu M; Fan Y; Zou G; Yang Q; Xu F
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):130-135. PubMed ID: 38650146
[TBL] [Abstract][Full Text] [Related]
5. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
Huang Q; Hou S; Zhu X; Liu S
World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
[TBL] [Abstract][Full Text] [Related]
7. Capn4 regulates Snail to promote the epithelial-mesenchymal transition of nasopharyngeal carcinoma by mediating the transcriptional activity of claudin-11.
Yang F; Wang F; Gao ZS; Quang GQ; Hu HB; Zheng M
Kaohsiung J Med Sci; 2023 Feb; 39(2):134-144. PubMed ID: 36354184
[TBL] [Abstract][Full Text] [Related]
8. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells.
Zeng Q; Liu YM; Liu J; Han J; Guo JX; Lu S; Huang XM; Yi P; Lang JY; Zhang P; Wang CT
Cell Death Dis; 2019 Aug; 10(8):588. PubMed ID: 31383854
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
12. CPVL suppresses metastasis of nasopharyngeal carcinoma through inhibiting epithelial-mesenchymal transition.
Wang X; Chen L; Huang K; Lin Y; Hong Y; Lin Z
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16473-16488. PubMed ID: 37712963
[TBL] [Abstract][Full Text] [Related]
13. NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma.
Zou Y; Yang R; Huang ML; Kong YG; Sheng JF; Tao ZZ; Gao L; Chen SM
J Exp Clin Cancer Res; 2019 Nov; 38(1):456. PubMed ID: 31699119
[TBL] [Abstract][Full Text] [Related]
14. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
15. As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li XJ; Peng LX; Shao JY; Lu WH; Zhang JX; Chen S; Chen ZY; Xiang YQ; Bao YN; Zheng FJ; Zeng MS; Kang TB; Zeng YX; Teh BT; Qian CN
Carcinogenesis; 2012 Jul; 33(7):1302-9. PubMed ID: 22610073
[TBL] [Abstract][Full Text] [Related]
16. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 Induces Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway.
Fei Z; Deng Z; Zhou L; Li K; Xia X; Xie R
Oncol Res; 2019 Jul; 27(7):801-807. PubMed ID: 30982497
[TBL] [Abstract][Full Text] [Related]
18. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
[TBL] [Abstract][Full Text] [Related]
19. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
Zhang W; Zhang Q; Cui Q; Xu Y
Hum Exp Toxicol; 2023; 42():9603271221150248. PubMed ID: 36607163
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
Wang X; Jin Q; Wang X; Chen W; Cai Z
Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
